OBJECTIVE: This study was performed to determine predictors of clinical influenza diagnosis among patients with laboratory-confirmed influenza. METHODS: Prospective, laboratory-confirmed surveillance for influenza was conducted among patients of all ages who were hospitalized or presented to the emergency department with fever and respiratory symptoms during 2009-2013. We evaluated all enrolled persons who had influenza confirmed by viral culture and/or polymerase chain reaction and received any discharge diagnosis. The primary outcome, clinical influenza diagnosis, was defined as (1) a discharge diagnosis of influenza, (2) a prescription of neuraminidase inhibitor, or (3) a rapid test positive for influenza virus. Bivariate analyses and multiple logistic regression modeling were performed. RESULTS: Influenza was diagnosed for 29% of 504 enrolled patients with laboratory-confirmed influenza and for 56% of 236 patients with high-risk conditions. Overall, clinical influenza diagnosis was predicted by race/ethnicity, insurance status, year, being hospitalized, having high-risk conditions, and receiving no diagnosis of bacterial infection. Being diagnosed with a bacterial infection reduced the odds of receiving an influenza diagnosis by >3-fold for all patients and for patients with high-risk conditions. CONCLUSIONS: Many influenza virus-positive patients, including those with high-risk conditions, do not receive a clinical diagnosis of influenza. The pattern of clinical diagnoses among influenza virus-positive patients suggests preferential consideration of bacterial diseases as a diagnosis.
OBJECTIVE: This study was performed to determine predictors of clinical influenza diagnosis among patients with laboratory-confirmed influenza. METHODS: Prospective, laboratory-confirmed surveillance for influenza was conducted among patients of all ages who were hospitalized or presented to the emergency department with fever and respiratory symptoms during 2009-2013. We evaluated all enrolled persons who had influenza confirmed by viral culture and/or polymerase chain reaction and received any discharge diagnosis. The primary outcome, clinical influenza diagnosis, was defined as (1) a discharge diagnosis of influenza, (2) a prescription of neuraminidase inhibitor, or (3) a rapid test positive for influenza virus. Bivariate analyses and multiple logistic regression modeling were performed. RESULTS:Influenza was diagnosed for 29% of 504 enrolled patients with laboratory-confirmed influenza and for 56% of 236 patients with high-risk conditions. Overall, clinical influenza diagnosis was predicted by race/ethnicity, insurance status, year, being hospitalized, having high-risk conditions, and receiving no diagnosis of bacterial infection. Being diagnosed with a bacterial infection reduced the odds of receiving an influenza diagnosis by >3-fold for all patients and for patients with high-risk conditions. CONCLUSIONS: Many influenza virus-positive patients, including those with high-risk conditions, do not receive a clinical diagnosis of influenza. The pattern of clinical diagnoses among influenza virus-positive patients suggests preferential consideration of bacterial diseases as a diagnosis.
Authors: Christine N Dao; Laurie Kamimoto; Mackenzie Nowell; Arthur Reingold; Ken Gershman; James Meek; Kathryn E Arnold; Monica Farley; Patricia Ryan; Ruth Lynfield; Craig Morin; Joan Baumbach; Emily Hancock; Shelley Zansky; Nancy M Bennett; Ann Thomas; Meredith Vandermeer; David L Kirschke; William Schaffner; Lyn Finelli Journal: J Infect Dis Date: 2010-09-15 Impact factor: 5.226
Authors: Timothy M Uyeki; Ramakrishna Prasad; Charles Vukotich; Samuel Stebbins; Charles R Rinaldo; Yu-Hui Ferng; Stephen S Morse; Elaine L Larson; Allison E Aiello; Brian Davis; Arnold S Monto Journal: Clin Infect Dis Date: 2009-05-01 Impact factor: 9.079
Authors: Anthony E Fiore; David K Shay; Karen Broder; John K Iskander; Timothy M Uyeki; Gina Mootrey; Joseph S Bresee; Nancy J Cox Journal: MMWR Recomm Rep Date: 2009-07-31
Authors: Gerry Fairbrother; Amy Cassedy; Ismael R Ortega-Sanchez; Peter G Szilagyi; Kathryn M Edwards; Noelle-Angelique Molinari; Stephanie Donauer; Diana Henderson; Sandra Ambrose; Diane Kent; Katherine Poehling; Geoffrey A Weinberg; Marie R Griffin; Caroline B Hall; Lyn Finelli; Carolyn Bridges; Mary Allen Staat Journal: Vaccine Date: 2010-05-31 Impact factor: 3.641
Authors: Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman Journal: Clin Infect Dis Date: 2009-04-15 Impact factor: 9.079
Authors: Fiona Havers; Swathi Thaker; Jessie R Clippard; Michael Jackson; Huong Q McLean; Manjusha Gaglani; Arnold S Monto; Richard K Zimmerman; Lisa Jackson; Josh G Petrie; Mary Patricia Nowalk; Krissy K Moehling; Brendan Flannery; Mark G Thompson; Alicia M Fry Journal: Clin Infect Dis Date: 2014-07-16 Impact factor: 9.079
Authors: John C Arnold; Kumud K Singh; Edmund Milder; Stephen A Spector; Mark H Sawyer; Shilpa Gavali; Carol Glaser Journal: Pediatr Infect Dis J Date: 2009-12 Impact factor: 2.129
Authors: Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia Journal: Clin Infect Dis Date: 2019-03-05 Impact factor: 9.079
Authors: Ikwo K Oboho; Anna Bramley; Lyn Finelli; Alicia Fry; Krow Ampofo; Sandra R Arnold; Wesley H Self; Derek J Williams; D Mark Courtney; Yuwei Zhu; Evan J Anderson; Carlos G Grijalva; Jonathan A McCullers; Richard G Wunderink; Andrew T Pavia; Kathryn M Edwards; Seema Jain Journal: Open Forum Infect Dis Date: 2016-12-27 Impact factor: 3.835
Authors: Benjamin J Smith; David J Price; Douglas Johnson; Bruce Garbutt; Michelle Thompson; Louis B Irving; Mark Putland; Steven Y C Tong Journal: Open Forum Infect Dis Date: 2020-07-03 Impact factor: 3.835